(Health) Relief might be on the horizon for the billions of people afflicted by BAFS (“Brief Accumulation of Phlegm Syndrome”). Otherwise known as “the clearing of the throat”, or, “coughing”, BAFS has become so common that the mathematical probability of knowing a sufferer stands still at 100%. And the picture gets no brighter when you look at the odds of being diagnosed yourself. “Unfortunately, 10 out of 10 people will personally encounter BAFS in his or her lifetime,” explains Henry Stein, M.D., one of the biochemists who helped create Fleyderchomerdehm, which is scheduled for FDA review in Spring, 2018.
“The level of unanimous, global acceptance of BAFS startles me,” said Stein, “and for many years I felt all alone in my concern.”
While known side effects of Fleyderchomerdehm include seizures, irreversible hearing loss, and pancreatitis, the benefits far outweigh the cons, according to Stein.
“One of the patients, a man I treat in my private practice, has to clear his throat several times during the course of a brief conversation. Sadly, this is no anomaly”, continued Stein, “it is the norm.”